AI's Role in Accelerating Drug Development and Clinical Trials | RegulatingAI Ft. Raphael Townshend

Поділитися
Вставка
  • Опубліковано 18 лис 2024
  • AI and RNA are revolutionizing drug discovery, promising a future where life-saving medications are developed faster and at lower costs.
    In this episode, Raphael Townshend, PhD, Founder and CEO of Atomic AI, sits down with me to discuss the intersection of AI and RNA in drug development. We explore how AI technologies can reduce the cost and time required for clinical trials and target previously incurable diseases.
    About Regulating AI:
    RegulatingAI is a dedicated non-profit organization designed for experts, mentors, and users of artificial intelligence (AI) with a keen interest in exploring the intersection of AI and regulation. We aim to unite individuals with diverse expertise and backgrounds, fostering collaboration to collectively advance the understanding and implementation of AI regulations.
    Key Takeaways:
    00 - 00:18 Episode Recap
    00:19 - Introduction
    02:09 Raphael's background in AI and biology, and founding of Atomic AI.
    05:59 Reducing time and failure rate in drug discovery with AI.
    07:16 AlphaFold's breakthrough in understanding molecular shapes using AI.
    09:23 Ensuring transparency and accountability in AI-driven drug discovery.
    12:22 Navigating intellectual property concerns in healthcare AI.
    15:34 Integrating AI with wet lab testing for accurate drug discovery results.
    17:31 Balancing intellectual property and open research in biotech.
    20:02 Addressing data privacy and security in AI algorithms.
    22:30 Educating users and healthcare professionals about AI in drug discovery.
    24:48 Collaborating with global regulators for AI-driven drug discovery innovations.
    Resources Mentioned:
    Raphael Townshend - / raphael-townshend-9154...
    Atomic AI | LinkedIn - / atomic-ai-rna
    AlphaFold - deepmind.googl...
    Atomic AI Homepage - atomic.ai/
    ATOM-1 Large Language Model - www.biospace.c...
    About your host
    Sanjay Puri is a recognized authority on US-India relations. He serves as the Chairman of the US-India Political Action Committee (USINPAC), a national, bipartisan political action committee representing Indian-Americans. He is also the founder of the Alliance for US India Business (AUSIB), an organization dedicated to strengthening economic ties between the US and India. He is also a successful technology entrepreneur, mentor, and investor.
    Thanks for listening to the Regulating AI: Innovate Responsibly podcast. If you enjoyed this episode, please leave a 5-star review to help get the word out about the show. And be sure to subscribe so you never miss another insightful conversation.
    #AIRegulation #regulatingaipodcast #innovationinAIRegulation
    Streaming On:
    Apple Podcast: podcasts.apple...
    Spotify: open.spotify.c...
    UA-cam: / @the_regulating_ai_pod...
    Join our fastest-growing AI Community:
    Discord: / discord
    Instagram: / regulating_ai
    Twitter: / regulatingai
    LinkedIn: / regulating-ai
    Facebook: / regulatingai
    Read Our Blogs, News & Updates:regulatingai.org/
    Join the Conversation:
    Leave your thoughts and questions in the comments below. We'd love to hear from you!

КОМЕНТАРІ •